Rationale Drug Therapy for The Management of Myocardial Infraction

Abstract

Myocardial Infarction (MI) is an important health concern, especially for the elderly. In this study, patients with MI

who were hospitalized to two hospitals had their medication treatment and associated variables thoroughly evaluated. The

results of demographic research showed that both sexes are affected by MI, with a high proportion of patients in the 50–59 age

range. The prevalence of concurrent illnesses, particularly hypertension and diabetes mellitus, highlights the necessity of

controlling co-morbidities in addition to MI. The considerable worry of polypharmacy also raises questions about possible

interactions and repercussions. The study also identified a dearth of patient education and counseling at the ward level,

highlighting the urgent need for patient-centered treatment and information sharing. In light of these results, we suggest adding

clinical chemists to the ward level to keep an eye on pharmaceutical regimens, spot probable interactions, and guarantee

patient safety. For myocardial infarction patients, increased patient education and counseling can give them the confidence to

take an active role in their care, eventually improving outcomes. This study clarifies the critical requirement for patient-

centered, logical medication therapy in the treatment of this potentially fatal illness.